Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

That is indeed interesting, if not entirely predictable. The fact that they're continuing to follow the ADXS-PSA patients is also a net positive, in my view. Signals at least a nominal interest from Merck, although I'm trying to hold back from getting too excited about it.